MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

Anika Therapeutics Inc

Gesloten

SectorGezondheidszorg

14.26 -0.21

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

14.18

Max

14.35

Belangrijke statistieken

By Trading Economics

Inkomsten

8.1M

-22M

Verkoop

-40M

-1.3M

EPS

-0.03

Winstmarge

1,694.961

Werknemers

288

EBITDA

52M

27M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+59.39% upside

Dividenden

By Dow Jones

Volgende Winsten

9 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-37M

199M

Vorige openingsprijs

14.47

Vorige sluitingsprijs

14.26

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

Anika Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 apr 2025, 17:01 UTC

Winsten
Belangrijke Marktbewegers

Aon Shares Sink After 1Q Profit Falls, Sales Miss Estimates

25 apr 2025, 16:10 UTC

Winsten
Belangrijke Marktbewegers

Coursera Shares Rise After 1Q Beat, Better-Than-Expected Revenue View

26 apr 2025, 18:14 UTC

Winsten

Tech Executives Are Starting to Talk Tariffs. What It May Mean for Apple, Amazon Earnings -- Barrons.com

26 apr 2025, 15:00 UTC

Winsten
Acquisities, Fusies, Overnames

Trump 2.0 Era Brings Flurry of Crypto Deals -- WSJ

26 apr 2025, 08:20 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

25 apr 2025, 21:24 UTC

Top Nieuws

Cargo Shipments From China to the U.S. Dwindle -- WSJ

25 apr 2025, 20:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

25 apr 2025, 20:45 UTC

Top Nieuws

Stocks Claw Back Most of April's Tariff Losses -- WSJ

25 apr 2025, 20:39 UTC

Winsten

The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week -- WSJ

25 apr 2025, 20:37 UTC

Top Nieuws

Trump Administration Lays Out Tariff Roadmap to Streamline Trade Talks -- WSJ

25 apr 2025, 20:19 UTC

Top Nieuws

Nasdaq Climbs More Than 1% as Stocks Finish Strong Week -- WSJ

25 apr 2025, 20:15 UTC

Winsten

Week's Best: A Dividend Expert's Best Advice -- Barrons.com

25 apr 2025, 19:23 UTC

Marktinformatie

U.S. Natural Gas Futures Extend Weekly Losses -- Market Talk

25 apr 2025, 19:18 UTC

Marktinformatie

Oil Futures End Choppy Week With Losses -- Market Talk

25 apr 2025, 18:47 UTC

Marktinformatie

Gold Extends Pullback to Close Week -- Market Talk

25 apr 2025, 18:39 UTC

Top Nieuws

Nasdaq, Dow Industrials About Flat; Analysts Caution on Trump Tariffs -- WSJ

25 apr 2025, 18:34 UTC

Acquisities, Fusies, Overnames

Goldman Sachs Upgrades Schwab Stock. Here's Why. -- Barrons.com

25 apr 2025, 18:32 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

25 apr 2025, 18:32 UTC

Marktinformatie
Winsten

Carriers See Tariffs Driving Up Phone Prices, Slowing Upgrades -- Market Talk

25 apr 2025, 18:08 UTC

Winsten

Sphere Entertainment Deal Is a Win for Shareholders as Banks Take a Hit -- Barrons.com

25 apr 2025, 17:55 UTC

Marktinformatie

U.S. Oil Rig Count Rises By 2 to 483 -- Market Talk

25 apr 2025, 17:40 UTC

Top Nieuws

Consumers Continue to Sour on the Economy -- 4th Update

25 apr 2025, 17:38 UTC

Winsten

Centene Stock Falls on Medicaid Cost Worries -- Barrons.com

25 apr 2025, 17:07 UTC

Marktinformatie

Oil Futures Turn Higher in Quiet Trade -- Market Talk

25 apr 2025, 16:54 UTC

Marktinformatie
Winsten

Mobile Carriers See Stronger Activity on Bigger Price Tags, Tariffs -- Market Talk

25 apr 2025, 16:46 UTC

Winsten

Reddit, Meta, and Pinterest Stocks Rise. How Alphabet's Earnings Are Giving Them a Boost. -- Barrons.com

25 apr 2025, 16:20 UTC

Marktinformatie
Winsten

Basic Materials Roundup: Market Talk

25 apr 2025, 16:12 UTC

Top Nieuws

Dow Industrials Fall; China Plans Economic Support During Trade Battle -- WSJ

25 apr 2025, 16:03 UTC

Winsten

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts -- Barrons.com

25 apr 2025, 15:52 UTC

Marktinformatie

Grains Mixed on Low Volume Trade -- Market Talk

Peer Vergelijking

Prijswijziging

Anika Therapeutics Inc Prognose

Koersdoel

By TipRanks

59.39% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 23 USD  59.39%

Hoogste 28 USD

Laagste 20 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Anika Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technische score

By Trading Central

14.02 / 14.7324Steun & Weerstand

Korte Termijn

Very Strong Bullish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.